On August 12, 2026, Reklaim Ltd. (TSXV: MYID; OTC: MYIDF) held its Annual General and Special Meeting of Shareholders in Toronto. Every matter submitted to shareholders for approval at the meeting was approved.
For a company built on giving people more control over their data, good governance isn't a footnote. It's the same principle applied to the business itself: transparency, accountability, and decisions made in the open. Here's what shareholders approved.
A four-person board, re-elected
Shareholders fixed the number of directors of the Company at four and re-elected the full slate to hold office until the next annual meeting of shareholders, or until their successors are duly elected or appointed:
- Neil Sweeney
- Robert Fernicola
- Brad Marks
- Jason Maguire
Auditors re-appointed
Shareholders voted in favour of re-appointing Davidson & Company LLP as auditors of the Company for the ensuing year, and authorized the Board of Directors to fix the auditors' remuneration.
Omnibus Equity Incentive Plan re-approved
Shareholders re-approved the Company's 10% rolling Omnibus Equity Incentive Plan. The plan provides Reklaim with a framework for granting equity-based compensation — including stock options, restricted share units (RSUs), deferred share units (DSUs) and performance share units (PSUs) — in accordance with its terms and applicable TSX Venture Exchange (TSXV) requirements.
Further details are set out in the Company's Management Information Circular dated July 15, 2026, available under the Company's profile on SEDAR+ and through Reklaim's Investor Relations portal.
June 30, 2026 share-based compensation grants approved
Disinterested shareholders approved, ratified and confirmed the grants of share-based compensation made by the Company on June 30, 2026 under the Omnibus Incentive Plan, consisting of 3,581,999 stock options and 1,099,999 RSUs.
The stock options are exercisable at $0.06 per common share for a period of three years from the date of grant. The RSUs were granted at a deemed value of $0.04 per unit, in accordance with the terms of the Omnibus Incentive Plan.
In accordance with TSXV Policy 4.4, votes attached to common shares held by participants in the June 30, 2026 grants, together with their associates and affiliates, were excluded from voting on the applicable resolution to the extent required by the TSXV.
The shareholder approval also authorizes the issuance of common shares upon the exercise of stock options and the settlement of RSUs, in accordance with the terms of the Omnibus Incentive Plan and applicable TSXV requirements.